EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Immune Signatures in Post-Acute Sequelae of COVID-19 (PASC) and Myalgia/Chronic Fatigue Syndrome (ME/CFS): Insights from the Fecal Microbiome and Serum Cytokine Profiles

Martin Tobi, Diptaraj Chaudhari iD, Elizabeth P Ryan iD, Noreen F Rossi iD, Orena Koka, Bridget Baxter, Madison Tipton, Taru S Dutt iD, Yosef Tobi iD, Benita McVicker iD, Mariana Angoa-Perez iD

Biomolecules · 25.06.2025 · 15 (7) · 928

DOI: 10.3390/biom15070928 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, online erschienen am 25.06.2025. Verfasst von Martin Tobi und 10 weiteren Autor:innen. Beteiligte Einrichtung: R&D Department, John D. Dingell VAMC, 4646 John R Street, Detroit, MI 48201, USA. Hauptthemen laut MEDLINE: COVID-19, Fatigue Syndrome, Chronic, Cytokines, Feces. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA, VA, Merit R&D #BX004127.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

While there are many postulates for the etiology of post-viral chronic fatigue and other symptomatology, little is known. We draw on our past experience of these syndromes to devise means which can expose the primary players of this malady in terms of a panoply participating biomolecules and the state of the stool microbiome. Using databases established from a large dataset of patients at risk of colorectal cancer who were followed longitudinally over 3 decades, and a smaller database dedicated to building a Long PASC cohort (Post-Acute Sequelae of COVID-19), we were able to ascertain factors that predisposed patients to (and resulted in) significant changes in various biomarkers, i.e., the stool microbiome and serum cytokine levels, which we verified by collecting stool and serum samples. There were significant changes in the stool microbiome with an inversion from the usual Bacillota and Bacteroidota species. Serum cytokines showed significant differences in MIP-1β versus TARC (CC chemokine ligand 17) in patients with either PASC or COVID-19 (p < 0.02); IL10 versus IL-12p70a (p < 0.02); IL-1b versus IL-6 (p < 0.01); MCP1 versus TARC (p < 0.03); IL-8 versus TARC (p < 0.002); and Eotaxin3 versus TARC (p < 0.004) in PASC. Some changes were seen solely in COVID-19, including MDC versus MIP-1α (p < 0.01); TNF-α versus IL-1-β (p < 0.06); MCP4 versus TARC (p < 0.0001). We also show correlates with chronic fatigue where an etiology was not identified. These findings in patients with positive criteria for PASC show profound changes in the microbiome and serum cytokine expression. Patients with chronic fatigue without clear viral etiologies also have common associations, including a history of tonsillectomy, which evokes a likely immune etiology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Fatigue Syndrome, ChronicCytokinesFecesGastrointestinal MicrobiomeHumansMaleFemaleMiddle AgedSARS-CoV-2AdultPost-Acute COVID-19 SyndromeBiomarkers

Stichwörter der Autor:innen

Adnab-9COVID-19Epstein Barr VirusLong COVIDPASC (Post Acute Sequelae of SARS-CoV-2 infection) or post-acute sequelae of CO…animal modelschronic fatiguechronic fatigue syndromecytokinescytomegalovirusdatabaseinnate immune systemmyalgic/encephalitisoligo-A-synthetasep87

Substanzen

CytokinesBiomarkers

Autor:innen und Institutionen

  • R&D Department, John D. Dingell VAMC, 4646 John R Street, Detroit, MI 48201, USA.
  • Department of Physiology, Wayne State University School of Medicine, Detroit, MI 48301, USA.
  • Department of Environmental and Radiological Health Sciences, School of Health System, Public Health, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523, USA.
  • Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68005, USA.

ORCID-Profile: Diptaraj Chaudhari, Elizabeth P Ryan, Noreen F Rossi, Taru S Dutt, Yosef Tobi, Benita McVicker, Mariana Angoa-Perez

Förderung

  • BLRD VA
  • VA
  • Merit R&amp;D #BX004127

Zitieren

APA

Tobi, M., Chaudhari, D., Ryan, E. P., Rossi, N. F., Koka, O., Baxter, B., Tipton, M., Dutt, T. S., Tobi, Y., McVicker, B., & Angoa-Perez, M. (2025). Immune Signatures in Post-Acute Sequelae of COVID-19 (PASC) and Myalgia/Chronic Fatigue Syndrome (ME/CFS): Insights from the Fecal Microbiome and Serum Cytokine Profiles. Biomolecules, 15(7), 928. https://doi.org/10.3390/biom15070928

Vancouver

Tobi M, Chaudhari D, Ryan EP, Rossi NF, Koka O, Baxter B, et al. Immune Signatures in Post-Acute Sequelae of COVID-19 (PASC) and Myalgia/Chronic Fatigue Syndrome (ME/CFS): Insights from the Fecal Microbiome and Serum Cytokine Profiles. Biomolecules. 2025;15(7):928. doi:10.3390/biom15070928

BibTeX
@article{Tobi2025,
  author = {Tobi, Martin and Chaudhari, Diptaraj and Ryan, Elizabeth P and Rossi, Noreen F and Koka, Orena and Baxter, Bridget and Tipton, Madison and Dutt, Taru S and Tobi, Yosef and McVicker, Benita and Angoa-Perez, Mariana},
  title = {Immune Signatures in Post-Acute Sequelae of COVID-19 (PASC) and Myalgia/Chronic Fatigue Syndrome (ME/CFS): Insights from the Fecal Microbiome and Serum Cytokine Profiles},
  journal = {Biomolecules},
  year = {2025},
  volume = {15},
  number = {7},
  pages = {928},
  doi = {10.3390/biom15070928}
}
Kostenlos starten →